Latest Breaking News On - Bio pharma inc - Page 2 : comparemela.com

BridgeBio Pharma : BBIO – Acoramidis AG10 TTR – ISA 2024 – Higher risk of mortality in previously hospitalized patients

Higher Risk of Mortality in Previously Hospitalized Patients: Insights From ATTRibute-CM Ahmad Masri1, Michele Emdin2, Keyur Shah3, Kunal Bhatt4,.

United statesSan franciscoPalo altoWestern australiaStanford universityDariusz korczykKunal bhattMichel khouriKevin alexanderJonathanc foxNoel dasguptaAhmad masriMichele emdinMartha groganMichael johnstoneSuresh siddhanti

BridgeBio Pharma : BBIO Acoramidis (AG10) TTR ISA 2024 Featured research in the ATTR CM landscape

Featured research in the ATTR-CM landscape May 29, 2024 Forward-Looking.

While the companyDrug administrationExchange commissionSecurities exchangeBio pharma incForward looking statementsSecurities actSecurities exchange actBridgebio pharmaAnnual report

Primecap Management Co CA Boosts Stock Holdings in BridgeBio Pharma, Inc (NASDAQ:BBIO)

Primecap Management Co. CA boosted its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 0.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 944,000 shares of the company’s stock after acquiring an additional 5,300 shares during the quarter. Primecap Management […]

New zealand generalNew zealandBridgebio pharmaBio pharmaRandalw scottPrimecap management coNorges bankBio pharma incNorthern trust corpJpmorgan chase coSecurities exchange commissionCharles schwab investment management incCantor fitzgeraldBridgebio pharma incExchange commissionWellington management group

BridgeBio Pharma, Inc (NASDAQ:BBIO) Shares Acquired by Primecap Management Co CA

Primecap Management Co. CA lifted its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 0.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 944,000 shares of the company’s stock after acquiring an additional 5,300 shares during the period. Primecap […]

Bio pharmaRandalw scottBio pharma incAssetmark incPrimecap management coBridgebio pharma company profileAtria wealth solutions incCommerce bankJpmorgan chase coCantor fitzgeraldBridgebio pharma incHealthcare of ontario pension plan trust fundExchange commissionSargent investment groupPrimecap managementBridgebio pharma

BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the 2024 ISA Meeting

BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the 2024 ISA Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBritish columbiaJean francois tambyKevinm alexanderMargot davisJuliand gillmoreBrettw sperryVikram baliMichel khouriMathew maurerAhmad masriJohn whangNitasha sarswatMazen hannaPablo garcia pavia